2021 Speakers

Helen Robinson

Head of Biology

Artios Pharma

Mark O’Connor

Chief Scientist, Oncology

AstraZeneca

Graeme Smith

Chief Scientific Officer

Artios Pharma

Oren Gilad

Chief Executive Officer

Atrin Pharmaceuticals

Panagiotis Konstantinopoulos

Associate Professor of Medicine

Harvard Medical School

John Pollard

Global Head Early Clinical Development & Translational Medicine Oncology

Bayer

Daniel Speidel

Co-Managing Director

Breakpoint Therapeutics

Nimrat Chatterjee

Assistant Professor

Univeristy of Vermont

Sotirios K. Sotiriou

Head of Biology & Co-Founder

FoRx Therapeutics

Andrea Loehr

Senior Director - Translational Medicine

Clovis Oncology

Kent Mouw

Assistant Professor of Radiation Oncology

Dana-Farber Cancer Institute

Simon Boulton

Senior Group Leader, Francis Crick Institute Co-founder & VP Science Strategy Artios Pharma

Alan D’Andrea

Professor, Radiation Oncology

Harvard Medical School

Geoffrey Shapiro

Director Early Drug Development Center

Dana-Faber Institute

Petar Jelinic

Director, Translational Oncology & Clinical Biomarkers

Merck

Nicola Curtin

Professor of Experimental Cancer Therapeutics

Newcastle University

Ruth Plummer

Professor of Experimental Cancer Medicine

Newcastle University

John Tainer

Professor

MD Anderson Cancer Centre

Wael Jdey

Head of in vitro Biology

Onxeo

Patrick Pilié

Assistant Professor, Genitourinary Medical Oncology

MD Anderson Cancer Center

Elaine Sanij

Senior Research Fellow

Peter MacCallum Cancer Centre

Karlene Cimprich

Professor of Chemical & Systems Biology

Stanford University

Tanja Stankovic

Professor - Cancer Genetics

University of Birmingham

Eric Brown

Associate Professor of Cancer Biology

University of Pennsylvania

Timothy A. Yap

Associate Professor, Investigational Cancer Therapeutics

MD Anderson Cancer Center

Louise Cadzow

Senior Director & Head of In Vivo Pharmacology

KSQ Therapeutics

Paul Secrist

Chief Scientific Officer

Cyteir Therapeutics

John Pascal

Professor of Biochemistry & Molecular Medicine Faculty of Medicine

Université de Montréal

Christian Frey

Associate Director Biology

Ideaya Biosciences

Tim J. Wigle

Director, Molecular Discovery

Ribon Therapeutics

Kirk Tanner

Chief Scientific Officer

National Brain Tumor Society

Ranjit S. Bindra

Associate Professor of Therapeutic Radiology

Yale School of Medicine